These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Utility of serum procalcitonin as a diagnostic guide in children with community-acquired pneumonia]. García-Zarza Martínez E; Ramos Amador JT; Rubio Gribble B; Corrales del Río E; Zeballos Sarrato G; Herrera Montes J An Pediatr (Barc); 2004 Mar; 60(3):279-81. PubMed ID: 14987523 [No Abstract] [Full Text] [Related]
26. [Etology and treatment of community acquired pneumonia in children]. Malek E; Lebecque P J Pharm Belg; 2007; 62(1):21-4. PubMed ID: 17508663 [TBL] [Abstract][Full Text] [Related]
27. Community-acquired bacteremic pneumonia due to Pasteurella multocida subspecies multocida in a patient with poor-control diabetes mellitus. Lee WS; Chen FL; Wang CH; Ou TY; Lin YH; Jean SS J Microbiol Immunol Infect; 2019 Feb; 52(1):163-164. PubMed ID: 29289552 [No Abstract] [Full Text] [Related]
38. Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia. Lu H; Zeng N; Chen Q; Wu Y; Cai S; Li G; Li F; Kong J J Int Med Res; 2019 Mar; 47(3):1232-1240. PubMed ID: 30732500 [TBL] [Abstract][Full Text] [Related]
39. Radiologic scales as a tool for the etiologic diagnosis of pediatric community-acquired pneumonia. Andrade DC; Nascimento-Carvalho CM J Pediatr (Rio J); 2018; 94(6):690-691. PubMed ID: 29990464 [No Abstract] [Full Text] [Related]
40. Advances in the causes and management of community acquired pneumonia in adults. Wunderink RG; Waterer G BMJ; 2017 Jul; 358():j2471. PubMed ID: 28694251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]